Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biora Therapeutics, Inc. - Common Stock
(NQ:
BIOR
)
0.6587
-0.0068 (-1.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biora Therapeutics, Inc. - Common Stock
< Previous
1
2
3
Next >
Biora Therapeutics Announces Two Poster Presentations at the Crohn’s & Colitis Congress
December 08, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Licenses Preeclampsia Rule-Out Test for Commercial Development
November 29, 2022
Avero Diagnostics to Develop and Commercialize, Enabling Potential Future Revenue for Biora Therapeutics
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
November 14, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update
November 07, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces $9.75 Million Direct Offering
November 07, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Sale of Cell-Free DNA Patent Rights
October 27, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Shares Data from Device Performance Study in Ulcerative Colitis Patients
October 25, 2022
Data Presented at the ACG Annual Meeting Demonstrates Successful Detection of Colon Entry and Topical Coverage Throughout Portion of Colon Implicated in Patients with Active Ulcerative Colitis
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Shares Five Posters Presented at American College of Gastroenterology Annual Scientific Meeting 2022
October 24, 2022
Presents Results on Device Performance Studies in Humans for Targeted Therapeutics Platform
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference
October 19, 2022
Further Demonstrating Possibilities for Systemic Delivery of Large Molecules
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Participate in 12th Annual Partnership Opportunities in Drug Delivery Conference
October 10, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Participate in Upcoming BTIG Investment Conference
July 26, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.